Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04548765 · ClinicalTrials.gov registry record · NA

Evaluation of Letters Promoting Colorectal Cancer Testing

A NA study, sponsored by Geisinger Clinic.

Completed
Registry status
NA
Development phase
14,644
Enrollment target

NCT04548765 is a NA study that has completed, run by Geisinger Clinic. The registered enrollment target is 14,644 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04548765, a NA study, has completed, sponsored by Geisinger Clinic.

COMPLETED
Registry status
NA
Development phase
14,644 participants
Enrollment target

Study Summary

In this evaluation, 4 different versions of letters are being sent with mailers promoting colorectal cancer screening with an at-home test. The researchers hypothesize that the use of behavioral nudges in the message should lead to increased colorectal cancer screening (either with the at-home test or a colonoscopy).

Interventions

  • BEHAVIORAL Letter
  • BEHAVIORAL Loss Frame and Fear Appeals
  • BEHAVIORAL Transparency
  • BEHAVIORAL Default Effect and Presentation of Alternatives
  • BEHAVIORAL Enhanced Fear Appeals and Decoy Effect

Trial Details

FieldValue
Enrollment Target 14,644 participants
Start Date 2020-07-24
Est. Completion 2021-07-23
Phase NA

Sponsor

Geisinger Clinic

107 total trials

What the Registry Record Tells You About NCT04548765

The ClinicalTrials.gov registry entry for NCT04548765 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14,644 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Geisinger Clinic, which has 107 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which Letter is the first listed.

NCT04548765 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04548765 about?

NCT04548765 is a clinical study titled "Evaluation of Letters Promoting Colorectal Cancer Testing". In this evaluation, 4 different versions of letters are being sent with mailers promoting colorectal cancer screening with an at-home test. The researchers hypothesize that the use of behavioral nudges in the message should lead to increased colorectal cancer screening (either with the at-home test ...

What is the current status of trial NCT04548765?

This trial is currently completed. It is a NA study. The enrollment target is 14,644 participants. The study started on 2020-07-24. Estimated completion is 2021-07-23.

What interventions are being tested in trial NCT04548765?

The interventions under investigation include: Letter (BEHAVIORAL), Loss Frame and Fear Appeals (BEHAVIORAL), Transparency (BEHAVIORAL), Default Effect and Presentation of Alternatives (BEHAVIORAL), Enhanced Fear Appeals and Decoy Effect (BEHAVIORAL).

Who is sponsoring clinical trial NCT04548765?

This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.